RVMD Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.20%

Insider Buying (Last 12 Months): $59,999,962.00

Insider Selling (Last 12 Months): $18,977,695.36

Revolution Medicines Insider Trading History Chart

Revolution Medicines Share Price & Price History

^$78.48

▲ +0.79 (1.02%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

Revolution Medicines Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/25/2025	Mark A. Goldsmith	Insider	Sell	60,000	$75.08	$4,504,800.00	247,863
11/18/2025	Mark A. Goldsmith	Insider	Sell	20,000	$70.38	$1,407,600.00	247,863
11/12/2025	Mark A. Goldsmith	Insider	Sell	20,000	$65.07	$1,301,400.00	247,863
11/7/2025	Mark A. Goldsmith	Insider	Sell	30,000	$60.31	$1,809,300.00	347,863
10/13/2025	Stephen Michael Kelsey	Insider	Sell	25,000	$48.54	$1,213,500.00	284,047
9/16/2025	Jack Anders	CFO	Sell	2,320	$45.82	$106,302.40	110,994
9/16/2025	Lin Wei	Insider	Sell	2,160	$45.82	$98,971.20	88,339
9/16/2025	Margaret A. Horn	COO	Sell	4,775	$45.82	$218,790.50	145,900
9/16/2025	Mark A. Goldsmith	Insider	Sell	13,411	$45.82	$614,492.02	452,309
9/16/2025	Stephen Michael Kelsey	Insider	Sell	5,367	$45.82	$245,915.94	284,047
9/15/2025	Stephen Michael Kelsey	Insider	Sell	25,000	$45.97	$1,149,250.00	289,414
9/11/2025	Stephen Michael Kelsey	Insider	Sell	100,000	$44.08	$4,408,000.00	289,414
9/3/2025	Jack Anders	CFO	Sell	5,238	$40.17	$210,410.46	113,314
9/2/2025	Jack Anders	CFO	Sell	4,762	$40.02	$190,575.24	113,314
3/17/2025	Jack Anders	CFO	Sell	1,864	$39.04	$72,770.56	115,006
3/17/2025	Margaret A. Horn	COO	Sell	3,058	$39.04	$119,384.32	153,533
3/17/2025	Mark A. Goldsmith	Insider	Sell	11,738	$39.04	$458,251.52	441,564
12/16/2024	Jack Anders	CFO	Sell	2,635	$45.40	$119,629.00	96,470
12/16/2024	Margaret A. Horn	COO	Sell	4,329	$45.40	$196,536.60	127,991
12/16/2024	Mark A. Goldsmith	Insider	Sell	11,714	$45.40	$531,815.60	325,056
12/5/2024	Thilo Schroeder	Director	Buy	1,304,347	$46.00	$59,999,962.00	2,096,612
10/14/2024	Stephen Michael Kelsey	Insider	Sell	16,666	$49.49	$824,800.34	264,408
10/11/2024	Jack Anders	CFO	Sell	10,000	$50.30	$503,000.00	98,932
10/11/2024	Jeff Cislini	General Counsel	Sell	6,000	$50.17	$301,020.00	45,634
10/11/2024	Margaret A. Horn	COO	Sell	50,000	$50.34	$2,517,000.00	132,320
10/11/2024	Mark A. Goldsmith	Insider	Sell	30,000	$50.36	$1,510,800.00	300,170
10/8/2024	Barbara Weber	Director	Sell	5,200	$48.02	$249,704.00	13,065
10/1/2024	Mark A. Goldsmith	Insider	Sell	10,000	$44.93	$449,300.00	300,170
8/1/2024	Mark A. Goldsmith	Insider	Sell	10,000	$45.88	$458,800.00	311,885
7/15/2024	Stephen Michael Kelsey	Insider	Sell	16,667	$46.47	$774,515.49	269,073
7/12/2024	Mark A. Goldsmith	Insider	Sell	25,000	$45.05	$1,126,250.00	311,885
7/9/2024	Jeff Cislini	General Counsel	Sell	2,399	$40.83	$97,951.17	47,088
7/9/2024	Sushil Patel	Director	Sell	2,155	$44.00	$94,820.00	19,948
6/26/2024	Jeff Cislini	General Counsel	Sell	2,000	$38.47	$76,940.00	49,487
6/24/2024	Stephen Michael Kelsey	Insider	Sell	200	$39.00	$7,800.00	269,073
5/3/2024	Jack Anders	CFO	Sell	10,000	$40.03	$400,300.00	101,959
4/10/2024	Mark A. Goldsmith	Insider	Sell	7,500	$35.48	$266,100.00	452,879
4/10/2024	Sushil Patel	Director	Sell	2,155	$37.00	$79,735.00	15,700
3/27/2024	Jeff Cislini	General Counsel	Sell	1,500	$30.99	$46,485.00	54,374
3/18/2024	Jack Anders	CFO	Sell	1,261	$31.58	$39,822.38	101,959
3/18/2024	Jeff Cislini	General Counsel	Sell	1,252	$31.58	$39,538.16	55,874
3/18/2024	Margaret A. Horn	COO	Sell	2,914	$31.58	$92,024.12	139,553
3/18/2024	Stephen Michael Kelsey	Insider	Sell	2,123	$31.58	$67,044.34	270,909
1/22/2024	Jeff Cislini	General Counsel	Sell	1,500	$27.00	$40,500.00	36,126
1/8/2024	Stephen Michael Kelsey	Insider	Sell	3,337	$29.01	$96,806.37	221,632
12/27/2023	Stephen Michael Kelsey	Insider	Sell	33,334	$29.01	$967,019.34	238,299
12/18/2023	Jack Anders	CFO	Sell	1,775	$25.90	$45,972.50	76,416
12/18/2023	Jeff Cislini	General Counsel	Sell	1,229	$25.90	$31,831.10	37,284
12/18/2023	Margaret A. Horn	COO	Sell	2,993	$25.90	$77,518.70	101,467
12/18/2023	Mark A. Goldsmith	Insider	Sell	8,165	$25.90	$211,473.50	376,167
12/15/2023	Margaret A. Horn	COO	Sell	5,000	$26.64	$133,200.00	104,460
11/20/2023	Jeff Cislini	General Counsel	Sell	1,500	$21.70	$32,550.00	38,513
10/16/2023	Margaret A. Horn	COO	Sell	25,000	$33.95	$848,750.00	96,960
10/11/2023	Stephen Michael Kelsey	Insider	Sell	16,667	$29.05	$484,176.35	273,721
9/28/2023	Jeff Cislini	General Counsel	Sell	2,000	$28.20	$56,400.00	40,013
9/18/2023	Jack Anders	CFO	Sell	1,427	$31.31	$44,679.37	53,667
9/18/2023	Jeff Cislini	General Counsel	Sell	1,214	$31.31	$38,010.34	42,013
9/18/2023	Margaret A. Horn	COO	Sell	2,514	$31.31	$78,713.34	96,960
9/18/2023	Stephen Michael Kelsey	Insider	Sell	2,060	$31.31	$64,498.60	290,388
9/15/2023	Margaret A. Horn	COO	Sell	5,000	$32.08	$160,400.00	99,474
9/1/2023	Barbara Weber	Director	Sell	15,000	$35.07	$526,050.00	15,825
9/1/2023	Jack Anders	CFO	Sell	20,000	$35.05	$701,000.00	55,094
9/1/2023	Mark A. Goldsmith	Insider	Sell	30,000	$35.05	$1,051,500.00	357,386
8/31/2023	Margaret A. Horn	COO	Sell	10,000	$34.05	$340,500.00	99,474
8/15/2023	Margaret A. Horn	COO	Sell	5,000	$30.53	$152,650.00	99,474
8/1/2023	Stephen Michael Kelsey	Insider	Sell	16,666	$29.19	$486,480.54	309,114
7/31/2023	Jeff Cislini	General Counsel	Sell	1,500	$26.02	$39,030.00	43,227
6/20/2023	Jack Anders	CFO	Sell	1,249	$24.89	$31,087.61	55,094
6/20/2023	Jeff Cislini	General Counsel	Sell	1,239	$25.14	$31,148.46	44,727
6/20/2023	Stephen Michael Kelsey	Insider	Sell	2,102	$24.89	$52,318.78	325,780
3/17/2023	Jack Anders	CFO	Sell	665	$21.78	$14,483.70	55,233
3/17/2023	Margaret A. Horn	Insider	Sell	1,230	$21.78	$26,789.40	100,062
3/10/2023	Thilo Schroeder	Director	Buy	100,000	$20.46	$2,046,000.00	1,553,134
3/7/2023	Thilo Schroeder	Director	Buy	550,000	$22.00	$12,100,000.00	1,453,134
12/19/2022	Jack Anders	CFO	Sell	658	$22.94	$15,094.52	29,298
12/19/2022	Xiaolin Wang	Insider	Sell	708	$22.94	$16,241.52	30,527

SEC Filings (Institutional Ownership Changes) for Revolution Medicines (NASDAQ:RVMD)

94.34% of Revolution Medicines stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Revolution Medicines Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/2/2025	Swiss Life Asset Management Ltd	6,280	$0.29M	0.0%	N/A	0.003%
11/19/2025	Danske Bank A S	2,100	$98K	0.0%	N/A	0.001%
11/17/2025	Woodline Partners LP	2,915,883	$136.17M	0.6%	+0.0%	1.508%
11/17/2025	TCG Crossover Management LLC	436,473	$20.38M	1.0%	N/A	0.226%
11/17/2025	Sender Co & Partners Inc.	8,637	$0.40M	0.0%	N/A	0.004%
11/17/2025	Verition Fund Management LLC	135,449	$6.33M	0.0%	-5.8%	0.070%
11/17/2025	Vestal Point Capital LP	630,000	$29.42M	1.3%	-47.5%	0.326%
11/17/2025	Polar Capital Holdings Plc	478,105	$22.33M	0.1%	-36.4%	0.247%
11/17/2025	Prelude Capital Management LLC	20,000	$0.93M	0.1%	N/A	0.010%
11/17/2025	Public Employees Retirement System of Ohio	54,143	$2.53M	0.0%	+0.6%	0.028%
11/17/2025	Paradigm Biocapital Advisors LP	6,223,291	$290.63M	8.3%	+2.1%	3.219%
11/17/2025	Mercer Global Advisors Inc. ADV	6,002	$0.28M	0.0%	N/A	0.003%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	9,196	$0.42M	0.0%	+23.1%	0.005%
11/17/2025	HighVista Strategies LLC	175,448	$8.19M	2.0%	+157.8%	0.091%
11/17/2025	Holocene Advisors LP	3,437,283	$160.52M	0.4%	-5.4%	1.778%
11/17/2025	Gotham Asset Management LLC	99,114	$4.63M	0.0%	N/A	0.051%
11/17/2025	Granahan Investment Management LLC	118,692	$5.54M	0.2%	-2.5%	0.061%
11/17/2025	Farallon Capital Management LLC	14,625,692	$683.02M	2.8%	+2.1%	7.566%
11/17/2025	Decheng Capital LLC	210,000	$9.81M	1.7%	-7.1%	0.109%
11/17/2025	Boxer Capital Management LLC	400,000	$18.68M	6.0%	-49.6%	0.207%
11/17/2025	Brevan Howard Capital Management LP	31,163	$1.46M	0.0%	-84.7%	0.016%
11/17/2025	Casdin Capital LLC	2,647,333	$123.63M	10.3%	-8.3%	1.369%
11/17/2025	Checkpoint Capital L.P.	492,300	$22.99M	7.7%	+75.8%	0.255%
11/17/2025	Baker BROS. Advisors LP	9,455,357	$441.57M	3.2%	+1.0%	4.891%
11/17/2025	California Public Employees Retirement System	230,974	$10.79M	0.0%	+7.7%	0.119%
11/17/2025	Bank of America Corp DE	753,867	$35.21M	0.0%	+30.7%	0.390%
11/17/2025	Aquatic Capital Management LLC	46,565	$2.18M	0.0%	-29.1%	0.024%
11/17/2025	Algert Global LLC	166,315	$7.77M	0.1%	+141.1%	0.086%
11/17/2025	Alliancebernstein L.P.	62,131	$2.90M	0.0%	+3.5%	0.032%
11/17/2025	Ameriprise Financial Inc.	1,224,759	$57.20M	0.0%	-8.9%	0.634%
11/14/2025	Schonfeld Strategic Advisors LLC	34,575	$1.62M	0.0%	+165.5%	0.018%
11/14/2025	Creative Planning	38,938	$1.82M	0.0%	-40.7%	0.020%
11/14/2025	Raymond James Financial Inc.	278,160	$12.99M	0.0%	-5.8%	0.144%
11/14/2025	Bellevue Group AG	5,573,838	$260.30M	5.4%	+21.7%	2.883%
11/14/2025	Caligan Partners LP	1,064,249	$49.70M	6.5%	+67.1%	0.551%
11/14/2025	Caisse de depot et placement du Quebec	108,400	$5.06M	0.0%	N/A	0.056%
11/14/2025	Deerfield Management Company L.P.	3,650,342	$170.47M	2.6%	+7.9%	1.888%
11/14/2025	Man Group plc	5,994	$0.28M	0.0%	-75.2%	0.003%
11/14/2025	ADAR1 Capital Management LLC	139,136	$6.50M	0.6%	+3.7%	0.072%
11/14/2025	Zurcher Kantonalbank Zurich Cantonalbank	41,801	$1.95M	0.0%	+10.2%	0.022%
11/14/2025	Acuta Capital Partners LLC	8,411	$0.39M	0.4%	-84.9%	0.004%
11/14/2025	Shay Capital LLC	46,000	$2.15M	0.2%	N/A	0.024%
11/14/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	341,367	$15.94M	0.0%	-31.8%	0.177%
11/14/2025	Two Sigma Investments LP	9,107	$0.43M	0.0%	N/A	0.005%
11/14/2025	Squarepoint Ops LLC	10,379	$0.49M	0.0%	-96.9%	0.005%
11/14/2025	Integral Health Asset Management LLC	400,000	$18.68M	1.3%	+23.1%	0.207%
11/14/2025	Wellington Management Group LLP	9,813,436	$458.29M	0.1%	-4.4%	5.076%
11/14/2025	Arrowpoint Investment Partners Singapore Pte. Ltd.	4,389	$0.21M	0.2%	N/A	0.002%
11/14/2025	Comerica Bank	490,216	$22.89M	0.1%	+72.0%	0.254%
11/14/2025	FORA Capital LLC	6,369	$0.30M	0.1%	N/A	0.003%
11/14/2025	General Atlantic L.P.	2,474,428	$115.56M	3.5%	N/A	1.280%
11/13/2025	Platinum Investment Management Ltd.	20,576	$0.96M	0.1%	N/A	0.011%
11/13/2025	Marshall Wace LLP	161,096	$7.52M	0.0%	+482.0%	0.083%
11/13/2025	Invesco Ltd.	200,942	$9.38M	0.0%	-11.5%	0.104%
11/13/2025	Sei Investments Co.	51,930	$2.43M	0.0%	+1.4%	0.027%
11/13/2025	UBS Group AG	1,088,965	$50.86M	0.0%	+111.6%	0.563%
11/13/2025	Connor Clark & Lunn Investment Management Ltd.	191,327	$8.94M	0.0%	+485.2%	0.099%
11/13/2025	BNP Paribas Financial Markets	424,681	$19.83M	0.0%	+15.6%	0.220%
11/13/2025	Franklin Resources Inc.	951,490	$44.44M	0.0%	+277.9%	0.492%
11/13/2025	Legal & General Group Plc	155,389	$7.26M	0.0%	-4.6%	0.080%
11/13/2025	Swiss National Bank	270,831	$12.65M	0.0%	+1.7%	0.140%
11/13/2025	Russell Investments Group Ltd.	124,639	$5.82M	0.0%	-34.5%	0.064%
11/13/2025	Private Advisor Group LLC	11,243	$0.53M	0.0%	N/A	0.006%
11/13/2025	Jefferies Financial Group Inc.	13,000	$0.61M	0.0%	-17.7%	0.007%
11/13/2025	Neo Ivy Capital Management	27,262	$1.27M	0.3%	-11.8%	0.014%
11/12/2025	Barclays PLC	290,449	$13.56M	0.0%	+13.3%	0.150%
11/12/2025	Smith Moore & CO.	6,000	$0.28M	0.0%	N/A	0.003%
11/12/2025	Dimensional Fund Advisors LP	1,440,818	$67.28M	0.0%	+44.6%	0.745%
11/12/2025	Legato Capital Management LLC	34,654	$1.62M	0.2%	+130.8%	0.018%
11/12/2025	Teachers Retirement System of The State of Kentucky	12,096	$0.57M	0.0%	-26.5%	0.006%
11/12/2025	Victory Capital Management Inc.	251,810	$11.76M	0.0%	-31.4%	0.130%
11/12/2025	CI Investments Inc.	1,617	$76K	0.0%	-39.9%	0.001%
11/12/2025	Fisher Asset Management LLC	7,305	$0.34M	0.0%	N/A	0.004%
11/12/2025	American Century Companies Inc.	451,014	$21.06M	0.0%	-0.8%	0.233%
11/12/2025	Rafferty Asset Management LLC	179,833	$8.40M	0.0%	+17.6%	0.093%
11/12/2025	Handelsbanken Fonder AB	58,375	$2.73M	0.0%	+25.1%	0.030%
11/12/2025	Westfield Capital Management Co. LP	2,513,967	$117.40M	0.5%	+52.4%	1.300%
11/12/2025	US Bancorp DE	3,168	$0.15M	0.0%	+170.3%	0.002%
11/12/2025	Catalyst Financial Partners LLC	4,828	$0.23M	0.0%	N/A	0.002%
11/10/2025	TD Asset Management Inc	535,604	$25.01M	0.0%	+5.5%	0.277%
11/10/2025	Raiffeisen Bank International AG	20,000	$0.92M	0.0%	N/A	0.010%
11/10/2025	China Universal Asset Management Co. Ltd.	42,767	$2M	0.2%	-44.8%	0.022%
11/10/2025	BIT Capital GmbH	1,522	$71K	0.0%	-22.1%	0.001%
11/10/2025	Persistent Asset Partners Ltd	13,627	$0.64M	0.4%	-27.1%	0.007%
11/7/2025	NEOS Investment Management LLC	126,921	$5.93M	0.0%	+34.7%	0.068%
11/7/2025	GSA Capital Partners LLP	10,080	$0.47M	0.0%	+18.8%	0.005%
11/7/2025	Vanguard Group Inc.	15,663,094	$731.47M	0.0%	-0.6%	8.379%
11/7/2025	JPMorgan Chase & Co.	2,498,327	$116.67M	0.0%	-11.9%	1.292%
11/7/2025	State of New Jersey Common Pension Fund D	58,308	$2.72M	0.0%	+10.4%	0.031%
11/7/2025	PNC Financial Services Group Inc.	9,941	$0.46M	0.0%	+29.2%	0.005%
11/7/2025	Shell Asset Management Co.	544	$25K	0.0%	-62.0%	0.000%
11/7/2025	GF Fund Management CO. LTD.	4,022	$0.19M	0.0%	-6.6%	0.002%
11/6/2025	Rhumbline Advisers	153,814	$7.18M	0.0%	-1.8%	0.082%
11/6/2025	S&CO Inc.	22,171	$1.04M	0.1%	+56.5%	0.012%
11/6/2025	Profund Advisors LLC	37,079	$1.73M	0.1%	+21.6%	0.020%
11/6/2025	ProShare Advisors LLC	6,661	$0.31M	0.0%	-4.2%	0.004%
11/6/2025	Candriam S.C.A.	868,724	$40.57M	0.2%	+20.7%	0.465%
11/6/2025	New York Life Investment Management LLC	17,909	$0.84M	0.0%	-2.9%	0.010%
11/5/2025	Fishman Jay A Ltd. MI	5,000	$0.23M	0.0%	N/A	0.003%
11/5/2025	Bessemer Group Inc.	243,867	$11.39M	0.0%	+0.1%	0.130%

Data available starting January 2016

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Its RAS(ON) inhibitors include RMC-6236 (multi), RMC-6291 (G12C), and RMC-9805 (G12D), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C), as well as programs focused on G12R and other targets. The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; and RMC-5552, which is in phase 1 clinical trial. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Today's Range

Now: $78.48

$76.53

$79.06

50 Day Range

MA: $59.75

$43.92

$78.48

52 Week Range

Now: $78.48

$29.17

$79.07

Volume

2,132,765 shs

Average Volume

2,278,929 shs

Market Capitalization

$15.17 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.96

Who are the company insiders with the largest holdings of Revolution Medicines?: Revolution Medicines' top insider shareholders include:
Thilo Schroeder (Director)
Mark A Goldsmith (Insider)
Stephen Michael Kelsey (Insider)
Margaret A Horn (COO)
Jack Anders (CFO)
Lin Wei (Insider)
Jeff Cislini (General Counsel)
Sushil Patel (Director)
Barbara Weber (Director)
Learn More about top insider investors at Revolution Medicines.
Who are the major institutional investors of Revolution Medicines?: Revolution Medicines' top institutional investors include:
Vanguard Group Inc. — 8.38%
Farallon Capital Management LLC — 7.57%
Wellington Management Group LLP — 5.08%
Baker BROS. Advisors LP — 4.89%
Paradigm Biocapital Advisors LP — 3.22%
Bellevue Group AG — 2.88%
Learn More about top institutional investors of Revolution Medicines stock.
Which institutional investors are selling Revolution Medicines stock?: Within the last quarter, RVMD stock was sold by these institutional investors:
Vestal Point Capital LP
Wellington Management Group LLP
Boxer Capital Management LLC
JPMorgan Chase & Co.
Squarepoint Ops LLC
Polar Capital Holdings Plc
Casdin Capital LLC
Holocene Advisors LP
In the last year, company insiders that have sold Revolution Medicines company stock include:
Thilo Schroeder (Director)
Mark A Goldsmith (Insider)
Stephen Michael Kelsey (Insider)
Margaret A Horn (COO)
Jack Anders (CFO)
Learn More investors selling Revolution Medicines stock.
Which institutional investors are buying Revolution Medicines stock?: In the last quarter, RVMD stock was purchased by institutional investors including:
General Atlantic L.P.
Bellevue Group AG
Westfield Capital Management Co. LP
Franklin Resources Inc.
UBS Group AG
Dimensional Fund Advisors LP
TCG Crossover Management LLC
Caligan Partners LP